人工智能驱动的重症肺炎早期预警:从数据整合到临床决策的路径与挑战
该综述指出重症肺炎进展快、异质性强,传统CURB-65和PSI等静态评分难以反映疾病动态演变。人工智能技术尤其是机器学习、深度学习和多模态融合模型在早期预警中展现应用优势,推动管理从被动应对向主动干预转变,但临床转化仍面临泛化能力不足、可解释性有限及前瞻性证据不足等挑战。
要点
- 传统CURB-65和PSI评分基于静态变量,个体化能力有限,难以反映重症肺炎动态演变。
- AI技术尤其是机器学习、深度学习和多模态融合模型可提升重症肺炎早期预警能力。
- AI预警系统的临床转化需多中心协同、数据标准化和机制研究融合。
核心结论
- AI驱动的早期预警体系正推动重症肺炎管理由被动应对向主动干预转变,但临床转化仍面临泛化能力不足、可解释性有限及前瞻性证据不足等挑战。
研究设计与样本
- 本文为综述,从临床问题出发结合国内外最新研究进展,重点评述AI在重症肺炎早期预警中的应用现状与关键技术路径,并结合我国代表性研究团队的工作基础与实践经验探讨未来方向。
主要发现
- 传统风险评分体系如CURB-65、PSI主要基于静态变量,难以反映疾病动态演变过程,且个体化能力有限。
- 人工智能技术,尤其是机器学习、深度学习及多模态融合模型,在提升重症肺炎早期预警能力方面展现出应用优势。
临床怎么用
- AI早期预警系统可辅助识别重症肺炎高风险患者,但需关注其泛化能力、可解释性及前瞻性证据。
局限性
- AI预警系统临床转化面临泛化能力不足、可解释性有限及前瞻性证据不足等挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe pneumonia, characterized by rapid progression and high heterogeneity, is a leading cause of patient mortality. Early identification of high-risk patients is crucial for improving outcomes. Traditional risk stratification tools, such as CURB-65 score and pneumonia severity index (PSI), primarily rely on static variables, which inadequately capture the dynamic evolution of the disease and offer limited capabilities for individualization. In recent years, artificial intelligence (AI) technologies, particularly machine learning, deep learning, and multimodal fusion models, have demonstrated significant potential for enhancing early warning capabilities for severe pneumonia. Starting from clinical challenges and integrating recent domestic and international advances, this review focuses on the current status of AI applications and key technological pathways in the early warning of severe pneumonia. By incorporating the foundational work and practical experiences of representative research teams in China, it further discusses future development directions in this field. AI-driven early warning systems are facilitating a shift in severe pneumonia management from passive response to proactive intervention. However, their clinical translation faces challenges, including insufficient generalizability, limited interpretability, and a lack of prospective validation. Future progress requires fostering multicenter collaboration, promoting data standardization, and integrating mechanistic studies to effectively embed AI into the clinical decision-making ecosystem. 重症肺炎病情进展迅速且异质性强,是导致患者死亡的主要原因之一,早期识别高风险患者对于改善预后至关重要。传统风险评分体系如CURB-65、PSI等主要基于静态变量,难以反映疾病动态演变过程,且个体化能力有限。近年来,人工智能(AI)技术,尤其是机器学习、深度学习及多模态融合模型,在提升重症肺炎早期预警能力方面展现出应用优势。本文从临床问题出发,结合国内外最新研究进展,重点评述AI在重症肺炎早期预警中的应用现状与关键技术路径,并结合我国代表性研究团队的工作基础与实践经验,探讨该领域未来发展方向。AI驱动的早期预警体系正在推动重症肺炎管理由被动应对向主动干预转变,但其临床转化仍面临泛化能力不足、可解释性有限及前瞻性证据不足等挑战。未来需通过多中心协同、数据标准化及机制研究融合,推动AI真正融入临床决策体系。.
引用
- He HY. [Artificial intelligence-driven early warning for severe pneumonia: pathways and challenges from data integration to clinical decision-making]. Zhonghua Jie He He Hu Xi Za Zhi. 2026. PMID: 42811558. doi:10.3760/cma.j.cn112147-20260429-00244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。